Cuba and Brazil: An important example of South-South collaboration in health biotechnology

MEDICC Review

Volumn 12, Issue 3, 2010, Pages 32-35

  Sáenz Sánchez, Tirso Walfredo ^a   Thorsteinsdóttir, Halla ^b   De Souza, Maria Carlota ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biomedical technology; Brazil; Cuba; International cooperation; Technology transfer; Technology, pharmaceutical

Indexed keywords

MENINGITIS VACCINE; NIMOTUZUMAB; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT ERYTHROPOIETIN; BACTERIAL VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ANEMIA; BRAZIL; COMMERCIAL PHENOMENA; CUBA; DEVELOPING COUNTRY; DRUG COST; GOAL ATTAINMENT; HEALTH CARE FINANCING; HEALTH SERVICE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEADERSHIP; MEDICAL TECHNOLOGY; NEISSERIA MENINGITIDIS; PUBLIC-PRIVATE PARTNERSHIP; REVIEW; VACCINE PRODUCTION; BIOSYNTHESIS; BIOTECHNOLOGY; IMMUNOLOGY; INTERNATIONAL COOPERATION; MANAGEMENT; MENINGITIS, BACTERIAL; POLITICS; TECHNOLOGY;

BACTERIAL VACCINES; BIOTECHNOLOGY; BRAZIL; CUBA; INTERNATIONAL COOPERATION; MENINGITIS, BACTERIAL; POLICY MAKING; POLITICS; TECHNOLOGY TRANSFER;

EID: 77956903734     PISSN: 15557960     EISSN: 15273172     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Rath A, Lealess S; Policy Research International Inc. The Forum on South-South Cooperation in Science and Technology: An Overview Document. Seoul; 2000 Feb. p. 77.
2. Hassan MH. Building Capacity in the Life Sciences in the Developing World. Cell. 2007 Nov 2;131(3):433-6.
3. Mokoena R. South-South co-operation: The case for IBSA. South African Journal of International Affairs. 2007 Winter-Spring;14(2):125-45.
4. Thorsteinsdóttir H, Melon CC, Ray M, Chakkalackal S, Li M, Cooper JE, et al. South-South Entrepreneurial Collaboration in Health Biotech. Nat Biotechnol. 2010 May;28(5):407-16.
5. Lage A. Connecting immunology research to public health: Cuban biotechnology. Nat Immunol. 2008 Feb;9(2):109-12.
6. Thorsteinsdóttir H, Sáenz TW, Quach U, Daar AS, Singer PA. Cuba - innovation through synergy. Nat Biotechnol. 2004 Dec. 22;Suppl:DC19-24.
7. Lage A. Connecting Science to Population Health: The "Closed Loop" Approach. MEDICC Rev. 2007;9(1):48.
8. Sáenz T. The path to innovation: the Cuban experience. International Journal of Technology Management and Sustainable Development. 2008 Dec;7(3):205-21.
9. Evenson D. Cuba's Biotechnology Revolution. MEDICC Rev. 2007;9(1):8-10.
10. Sotolongo F, Campa C, Casanueva V, Fajardo EM, Cuevas IE, González N. Cuban meningococcal BC vaccine: Experiences and Contributions from 20 Years of Application. MEDICC Rev. 2007;9(1):16-8.
11. Saurez G, Cabanas R, Zaldívar M, Garnier T, Iglesias B, Piedra P, et al. Clinical Experience with Nimotuzumab in Cuban Pediatric Patients with Brain Tumors, 2005 to 2007. MEDICC Rev. 2009;11(3):27-33.
12. Vérez-Bencomo V, Fernández-Santana V, Hardy E, Toledo ME, Rodríguez MC, Heynngnezz L, et al. A Synthetic Conjugate Polysaccaride Vaccine against Haemophilus Influenzae Type b. Science. 2004 Jul 23;305(5683):522-5.
13. Cooper RS, Kennelly JF, Ordunez-Garcia PO. Health in Cuba. Int J Epidemiol. 2006;35(4):817-24.
14. Blunden M. South-South Development Cooperation: Cuba's Health Programme in Africa. International Journal of Cuban Studies. 2008 Jun;1(1):1-11.
15. Interview evidence with CITMA, Ministry of Science, Technology and the Environment, Havana, Cuba.
16. World Development Indicators Database: Gross Domestic Product 2008. World Bank.
17. Organisation for Economic Co-Operation and Development (OECD). Globalisation and Emerging Economies [Internet]. Policy Briefs. 2009 Mar;8 p. Available from: http://www.oecd.org/dataoecd/35/34/42324460.pdf
18. Petherick A. High hopes for Brazilian Science. Nature. 2010 Jun 10;465(7299):674-5.
19. Ministry of Science and Technology (BR). Brasil: Dispêndio nacional em ciência e tecnologia (C&T)(1), 2000-2008 [Internet]. Brasilia: Ministry of Science and Technology (BR); c2008 [updated 2010 Jun 7; cited 2008 Jul 28]. Available from: http://www.mct.gov.br/index.php/content/view/9058.html
20. Ferrer M, Thorsteinsdóttir H, Quach U, Singer PA, Daar AS. The scientifi c muscle of Brazil's health biotechnology. Nat Biotechnol. 2004 Dec;22 Suppl:DC8-12.
21. Rezaie R, Frew SE, Sammut SM, Maliakkal MR, Daar AS, Singer PA. Brazilian health biotechnology - fostering crosstalk between public and private sectors. Nat Biotechnol. 2008 Jun;26(6):627-44. (Pubitemid 351809583)
22. Thorsteinsdóttir H, Archambault E, Aranachalam S, Daar AS, Singer PA. Health Biotechnology Publishing Takes-Off in Developing Countries. Int J Biotechnol. 2006;8(1/2):23-43.
23. Tura BR, Martino HF, Gowdak LH, dos Santos RR, Dohmann HF, Krieger JE, et al. Multicenter randomized trial of cell therapy in cardiopathies - MiHeart Study. Trials. 2007 Jan 18;8:2.
24. See CABBIO- Centro Argentino Brasileño de Biotecnología, http://www.mincyt.gov.ar/cabbio2.htm
25. See MERCOSUR, Mercado Común del Sur, http://www.mercosur.int
26. See PROSUL, http://www.cnpq.br/editais/ct/2008/011.htm
27. See PRO AFRICA, http://www.cnpq.br/editais/ct/2008/012.htm
28. See IBSA, http://www.ibsa-trilateral.org/
29. World Health Organization. Meningitis in Africa: Hundreds of thousands vaccinated [Internet]. Geneva: World Health Organization; 2007 March 16. [about 3 screens]. Available from: http://www.who.int/mediacentre/news/notes/2007/np12/ en/index.html